세계의 소변 검사 시장 보고서(2025년)
Urinalysis Global Market Report 2025
상품코드 : 1821656
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

소변 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.2%로 54억 3,000만 달러로 성장할 것입니다. 예측 기간의 성장은 현장진단 검사(POCT), 만성질환 관리, 고령화, 예방의료, 원격 모니터링, 원격의료에 기인합니다. 예측 기간의 주요 동향으로는 혁신 의약품 승인, 기술 혁신, 맞춤형 의료, 만성질환 모니터링 등이 있습니다.

향후 5년간 9.2%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 캐나다에서 공급되는 자동 소변 분석기 및 검사 스트립의 비용을 상승시킴으로써 미국의 검사실 효율성을 떨어뜨리고 임상 병리학 지출을 증가시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장의 고조와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것입니다.

소변 검사 시장은 노령인구의 증가로 인해 성장이 예상됩니다. 65세 이상 노인으로 구성된 노령 인구는 면역력 저하와 노화의 영향으로 다양한 질병에 시달리는 경우가 많습니다. 이 계층의 건강 문제 중 요로감염(UTI)의 위험 증가는 주목할 만합니다. 소변의 시각적, 화학적, 현미경적 성분을 검사하는 소변 검사는 당뇨병, 신장질환, 비뇨기 감염 등 노년층에 만연한 다양한 질병을 확인하고 관리하는 데 중요한 역할을 하고 있습니다. 세계보건기구(WHO)에 따르면, 2030년까지 전 세계 인구의 6분의 1이 60세 이상의 노인이 될 것이며, 그 수는 14억 명에 달할 것이라고 합니다. 전 세계 60세 이상 인구는 2050년까지 21억 명으로 두 배로 증가할 것으로 예상됩니다. 고령자, 특히 80세 이상 노인의 증가는 노인 인구의 건강 관리 요구에 대응하는 소변 검사의 중요성을 강조하고, 그 결과 소변 검사 시장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

A urinalysis, commonly known as a urine test, is a diagnostic examination that assesses the visual, chemical, and microscopic elements present in urine. It evaluates the appearance, concentration, and content of urine, encompassing various tests to detect and measure compounds that are excreted in urine through a single sample. This diagnostic tool is employed to identify and manage a range of health conditions, including diabetes, kidney disease, and urogenital infections.

The primary test types within urinalysis include pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. Pregnancy and fertility tests specifically focus on detecting a hormone, human chorionic gonadotropin (HCG), in blood or urine to confirm pregnancy or aid couples in family planning decisions. Regardless of pregnancy intentions, these tests assist in determining pregnancy status. Products used in urinalysis procedures consist of consumables and instruments, applied in diagnosing conditions such as urinary tract infections (UTIs), kidney disease, liver disease, diabetes, hypertension, among others. Urinalysis is utilized across various settings including diagnostic laboratories, hospitals, clinics, home care settings, as well as research laboratories and institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The urinalysis market research report is one of a series of new reports from The Business Research Company that provides urinalysis market statistics, including urinalysis industry global market size, regional shares, competitors with a urinalysis market share, detailed urinalysis market segments, market trends and opportunities, and any further data you may need to thrive in the urinalysis industry. This urinalysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urinalysis market size has grown strongly in recent years. It will grow from $3.57 billion in 2024 to $3.82 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising healthcare expenditure, healthcare infrastructure, regulatory changes and standardization, drug screening and forensics, clinical laboratory practices.

The urinalysis market size is expected to see strong growth in the next few years. It will grow to $5.43 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to point-of-care testing (POCT), chronic disease management, aging population, preventive healthcare, remote monitoring and telemedicine. Major trends in the forecast period include innovative drugs approvals, technological innovations, personalized medicine, chronic disease monitoring.

The forecast of 9.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of automated urine analyzers and test strips sourced from Germany and Canada, thereby reducing lab efficiency and elevating clinical pathology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The urinalysis market is anticipated to witness growth due to the rising geriatric population. The geriatric population, comprising individuals aged 65 and beyond, often experiences various diseases due to lower immunity and the effects of aging. Among the health concerns in this demographic, the increased risk of urinary tract infections (UTI) is notable. Urinalysis, which examines the visual, chemical, and microscopic components of urine, plays a crucial role in identifying and managing various illnesses prevalent in the geriatric population, including diabetes, kidney disease, and urogenital infections. According to the World Health Organization, by 2030, six people in the world will be aged 60 or older, reaching 1.4 billion individuals. The global population aged 60 and older is expected to double to 2.1 billion by 2050. The escalating number of elderly individuals, particularly those aged 80 and older, underscores the significance of urinalysis in addressing the healthcare needs of the geriatric population and, consequently, driving the urinalysis market.

The increasing incidence of chronic kidney disease is anticipated to drive the growth of the urinalysis market in the future. Chronic kidney disease is characterized by the kidneys' diminished ability to filter blood effectively due to gradual damage and loss of function. Urinalysis plays a crucial role in diagnosing, monitoring, and managing chronic kidney disease (CKD), offering valuable insights into kidney health and overall bodily function. For example, in June 2023, publications by the Oxford University Press, a UK-based department of the University of Oxford, projected that the prevalence of chronic kidney disease (CKD) in the UK would rise by 4%, increasing from 8.27 million to 8.61 million individuals between 2022 and 2032. Therefore, the rising prevalence of chronic kidney disease is fueling the growth of the urinalysis market.

Technologically advanced instruments, incorporating artificial intelligence (AI) technology in urine analysis devices, represent a key trend gaining popularity in the urinalysis market. Notably, Olive Diagnostics, an Israel-based health tech company, launched Olive KG in February 2022. This urinalysis sensor device, powered by AI, provides real-time health alerts and early detection of disease progression. Olive KG measures various parameters, including red blood cells, proteins, ketones, nitrites, pH, volume, pressure, color, and urine frequency. Designed as a toilet-mountable Internet of Medical Things (IoMT) device, Olive KG delivers real-time personal data while adhering to GDPR and HIPPA act criteria. The integration of AI technology in urinalysis instruments exemplifies a technological advancement that enhances the efficiency and capabilities of urine analysis, contributing to the market's growth.

Major players in the urinalysis market are actively engaged in developing innovative products, such as urine particle analyzers, to secure a competitive advantage. Urine analyzers are clinical devices designed for automated urine testing, offering capabilities for the detection and quantification of multiple analytes. Urine particle analyzers, in particular, provide enhanced accuracy and precision compared to manual microscopy, contributing to the standardization of urine particle analysis and reducing inter-observer variability. A notable example of this trend is Sysmex Europe SE, a Germany-based automated in vitro diagnostics provider, which introduced the UF-1500 Fully Automated Urine Particle Analyzer in April 2023. This innovative device is engineered to achieve a significant reduction in footprint (approximately 30%) while maintaining high levels of performance and usability. Leveraging cutting-edge fluorescence flow cytometry technology, similar to Sysmex's flagship UF-5000, the UF-1500 caters to diverse customer needs. It serves as a fully automated urinalysis workstation for both developed and emerging markets, as well as backup and satellite systems for extensive facilities that have previously installed the UN-Series. Additionally, the UF-1500 supports connectivity to Sysmex's UC-3500 urine chemistry analyzers.

In June 2022, Healthy.io Ltd., a US-based healthcare company specializing in remote clinical testing and services, acquired Inui Health for $9 million. This acquisition enabled Healthy.io Ltd. to acquire smartphone diagnostics platforms and various at-home testing services, which will enhance the company's growth in the smartphone diagnostic market. Inui Health is a US-based medical diagnostics company that offers consumers the ability to perform urinalysis at home using their smartphones.

Major companies operating in the urinalysis market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health Inc., Abbott Laboratories, Danaher Corporation, Beckman Coulter Inc., Sysmex Corporation, ARKRAY Inc., ACON Laboratories Inc., Bio-Rad Laboratories Inc., URIT Medical Electronic Group Co Ltd., 77 Elektronika Kft, Thermo Fisher Scientific Inc., Teco Diagnostics, Mindray Medical International Limited, Quidel Corporation, Becton Dickinson and Company, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Guangzhou Wondfo Biotech Co. Ltd., Chembio Diagnostic Systems Inc, Immunostics Inc., Inova Diagnostics Inc., Meridian Bioscience Inc., Fapon Biotech Inc., Nanjing Norman Biological Technology Co. Ltd., OraSure Technologies Inc., Hologic Inc., Randox Laboratories Ltd., Qiagen N.V

North America was the largest region in the urinalysis market in 2024. The regions covered in the urinalysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the urinalysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urinalysis market consists of revenues earned by entities by providing urinalysis services by providing visual exam of urine, dipstick test, screening tests, reagents test, culture test and microscopic exam of urine. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinalysis market also includes sales of automated urine analyzers, point of care analyzers, integrated urine analyzers, strip reader connect system equipment which are used in providing urinalysis services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Urinalysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on urinalysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for urinalysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urinalysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Urinalysis Market Characteristics

3. Urinalysis Market Trends And Strategies

4. Urinalysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Urinalysis Growth Analysis And Strategic Analysis Framework

6. Urinalysis Market Segmentation

7. Urinalysis Market Regional And Country Analysis

8. Asia-Pacific Urinalysis Market

9. China Urinalysis Market

10. India Urinalysis Market

11. Japan Urinalysis Market

12. Australia Urinalysis Market

13. Indonesia Urinalysis Market

14. South Korea Urinalysis Market

15. Western Europe Urinalysis Market

16. UK Urinalysis Market

17. Germany Urinalysis Market

18. France Urinalysis Market

19. Italy Urinalysis Market

20. Spain Urinalysis Market

21. Eastern Europe Urinalysis Market

22. Russia Urinalysis Market

23. North America Urinalysis Market

24. USA Urinalysis Market

25. Canada Urinalysis Market

26. South America Urinalysis Market

27. Brazil Urinalysis Market

28. Middle East Urinalysis Market

29. Africa Urinalysis Market

30. Urinalysis Market Competitive Landscape And Company Profiles

31. Urinalysis Market Other Major And Innovative Companies

32. Global Urinalysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Urinalysis Market

34. Recent Developments In The Urinalysis Market

35. Urinalysis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기